ad image

Generics

1 / 4
How Can (Bio)pharmaceutical Companies Contribute to Improving Global Access to Essential Medications?
Global Access

How Can (Bio)pharmaceutical Companies Contribute to Improving Global Access to Essential Medications?

Pharma's Almanac

PAO-08-24-RT-02Aug 07, 2024
Maximizing Outsourcing Benefits for Virtual Pharma Companies
CDMO

Maximizing Outsourcing Benefits for Virtual Pharma Companies

William Kazimier

Tedor Pharma Services

PAO-09-23-CL-08Jan 11, 2024
Redesigning ANDA or Novel Drug Products at All Stages for the U.S. Market
CDMO

Redesigning ANDA or Novel Drug Products at All Stages for the U.S. Market

Tedor Pharma Services

PAO-08-23-CL-06Sep 26, 2023
Trends Shaping the Dynamic Market for Parenterals
Parenterals

Trends Shaping the Dynamic Market for Parenterals

Marga Viñes

Grifols

PAP-Q3-20-CL-018Sep 29, 2020
Perrigo
FDA Approval

Perrigo and Catalent Announce FDA Approval of Perrigo's AB-Rated Generic Version of ProAir® HFA

Perrigo

PR-M02-20-NI-041Feb 27, 2020
Transparency Market Research
Market Prediction

Popularity of Generic Drugs Poised to Overshadow Atherosclerosis Drugs Market Growth

Transparency Market Research

PR-M01-20-NI-022Jan 15, 2020
Seqens
Generics

Seqens North America Identifies Trends Affecting the Generic Drugs Sector in 2020

Seqens

PR-M01-20-NI-021Jan 15, 2020
ANI Pharmaceuticals, Inc.
M&A

ANI Pharmaceuticals Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd.

ANI Pharmaceuticals, Inc.

PR-M01-20-NI-019Jan 14, 2020
Amneal Pharmaceuticals Inc.
Generic

Amneal Announces Approval of Generic Version of Amicar®

Amneal Pharmaceuticals Inc.

PR-M09-19-NI-024Sep 10, 2019
China Eases Generic Drug Market Shake-Up
Generics

China Eases Generic Drug Market Shake-Up

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M08-19-NI-001Aug 01, 2019
U.S. Food & Drug Administration
Generics

FDA Approves First Generics of Lyrica

U.S. Food & Drug Administration

PR-M07-19-NI-060Jul 23, 2019
Novadoz Pharmaceuticals
FDA Approval

MSN Labs/Novadoz Pharmaceuticals Early Success Continues With FDA Approval Of Generic Abiraterone

Novadoz Pharmaceuticals

PR-M07-19-NI-045-2367Jul 17, 2019
Mallinckrodt Modifies Specialty Generics Spinout Portfolio Composition
Generics

Mallinckrodt Modifies Specialty Generics Spinout Portfolio Composition

Nice Insight

PAO-M06-19-NI-004Jun 13, 2019
Mallinckrodt Pharmaceuticals
Generics

Mallinckrodt Updates Plans for Company Separation and Spin-Off of Specialty Generics Business to Shareholders

Mallinckrodt Pharmaceuticals

PR-M05-19-NI-087May 31, 2019
State Lawsuit Charges Generic Makers with Price Fixing
Generics

State Lawsuit Charges Generic Makers with Price Fixing

Nice Insight

PAO-M05-19-NI-032May 29, 2019
Being at the Right Place at the Right Time
Generics

Being at the Right Place at the Right Time

Ori Gutwerg

Taro Pharmaceutical Industries

PAP-Q2-2019-CL-033May 24, 2019
Teva Pharmaceutical Industries
Generics

Teva Announces Launch of a Generic Version of Tarceva® (erlotinib) Tablets in the United States

Teva Pharmaceutical Industries

PR-M05-19-NI-045May 15, 2019
First Generic Nalaxone Nasal Spray Approved by FDA
Generic

First Generic Nalaxone Nasal Spray Approved by FDA

Emilie Branch

Pharma's Almanac

PAO-M05-19-NI-006May 02, 2019
ResearchandMarkets
Generics

The Generic Pharmaceutical Market in Kenya & Nigeria - Forecast to 2022

ResearchandMarkets

PR-M04-19-NI-079Apr 25, 2019
Teva Pharmaceutical Industries
Generics

Teva Announces Launch of a Generic Version of VESIcare® (solifenacin succinate) Tablets in the United States

Teva Pharmaceutical Industries

PR-M04-19-NI-072Apr 23, 2019
1 / 4